U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07337434) titled 'To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital' on Dec. 17, 2025.
Brief Summary: This study aims to compare efficacy of methotrexate vs apremilast in the management of chronic plaque psoriasis.Given the high prevalence of psoriasis in Pakistan and the significant psychological impact on patients, particularly in Peshawer,this study will provide valuable insights into optimal treatment strategies.
Study Start Date: Dec. 25, 2025
Study Type: INTERVENTIONAL
Condition:
Chronic Plaque Psoriasis
Intervention:
DRUG: Methotrexate
Gro...